Pharmacological Management of Depressive Episodes
Publisher
Springer Healthcare Ltd.
Reference68 articles.
1. Fountoulakis KN, Vieta E, Sanchez-Moreno J, et al. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord. 2005;86:1-10.
2. Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11:225-255.
3. Goodwin GM; Consensus Group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition — recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009;23:346-388.
4. Grunze H, Vieta E, Goodwin G, et al. WFSBP Task Force on Treatment Guidelines for Bipolar Disorders. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11:81-109.
5. Bauer M, Ritter P, Grunze H, et al. Treatment options for acute depression in bipolar disorder. Bipolar Disord. 2012;14(suppl 2):37-50.